New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic- cytotoxic agents

European Journal of Medicinal Chemistry

Volumn 35, Issue 1, 2000, Pages 21-30

  Ortega, Miguel Ángel ^a   Morancho, María José ^a   Martínez Crespo, Francisco Javier ^a   Sainz, Yolanda ^a   Montoya, María Elena ^b   López De Ceráin, Adela ^a   Monge, Antonio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

Author keywords

Bioreductive activation; Hypoxia cytotoxicity; Quinoxaline 1,4 di N oxide; Solid tumour

Indexed keywords

7 CHLORO 3 (4 METHYLPIPERAZIN 1 YL) 2 QUINOXALINECARBONITRILE 1,4 DI N OXIDE; CYTOTOXIC AGENT; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN;

EID: 0034009248     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00112-4     Document Type: Article

References (26)

1. Moulder J.E., Rockwell S. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;695-715.
2. Urtasun R.C., Chapman J.C., Raleigh J.A., Franko A.J., Koch C.J. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1263-1267.
3. Vaupel P., Schlenger K., Knoop C., Höckel M. Cancer Res. 51:1991;3316-3322.
4. Vaupel P., Kallinowsky F., Okunieff P. Cancer Res. 49:1989;6449-6465.
5. Teicher B.A., Lazo J.S., Sartorelli A.C. Cancer Res. 41:1981;73-81.
6. Rice G.C., Hoy C., Schimke R.T. Proc. Natl. Acad. Sci. USA. 1986;5978-5982.
7. Lin A.J., Cosby L.A., Shansky C.W., Sartorelli A.C. J. Med. Chem. 15:1972;1247-1252.
8. Walton M.I., Wolf C.R., Workman P. Int. J. Radiat. Oncol. Biol. Phys. 6:1989;983-986.
9. Aboagye E.O., Lewis A.D., Tracy M., Workman P. Biochem. Pharmacol. 54:1997;1217-1224.
10. Lee H.H., Wilson W.R., Ferry D.M., van Zilj P., Pullen S.M., Denny W.A. J. Med. Chem. 39:1996;2508-2517.
11. Siim B.G., Atwell G.J., Anderson R.F., Wardman P., Pullen S.M., Wilson W.R., Denny W.A. J. Med. Chem. 40:1997;1381-1390.
12. Naylor M.A., Swann E., Everett S.A., Jaffar M., Nolan J., Robertson N., Lockyer S.D., et al. J. Med. Chem. 41:1998;2720-2731.
13. Brown J.M. Br. J. Cancer. 67:1993;1163-1170.
14. Monge A., Palop J.A., López de Ceráin A., Senador V., Martínez-Crespo F.J., Sainz Y., et al. J. Med. Chem. 38:1995;1786-1792.
15. Monge A., Martínez-Crespo F.J., López de Ceráin A., Palop J.A., Narro S., Senador V., et al. J. Med. Chem. 38:1995;4488-4494.
16. Monge A., Palop J.A., González M., Martínez-Crespo F.J., López de Ceráin A., Sainz Y., et al. J. Heterocycl. Chem. 32:1995;1213-1217.
17. Martínez-Crespo F.J., Palop J.A., Sainz Y., Narro S., Senador V., González M., et al. J. Heterocycl. Chem. 33:1996;1671-1677.
18. Ley K., Seng F. Synthesis. 1975;415-422.
19. Cheeseman G.W.H., Cookson R.F. Condensed Pyrazines. 1979;35-38 J. Wiley and sons, New York.
20. Albini A., Pietra S. Heterocyclic N-oxides. 1991;187-189 CRC Press, Florida.
21. Haddadin M.J., Issidorides C.H. Heterocycles. 35:1993;1503-1525.
22. Monge A., Palop J.A., Piñol A., Martínez-Crespo F.J., Narro S., González M., et al. J. Heterocycl. Chem. 31:1994;1135-1139.
23. Doyle M.P., Siegfried B., Dellaria J.F. Jr.,. J. Org. Chem. 42:1977;2426-2431.
24. Kurasawa Y., Takada A., Kim H.S. J. Heterocycl. Chem. 32:1995;1085-1114.
25. Jarrar A.A. J. Heterocycl. Chem. 15:1978;177-179.
26. Ortega M.A., Sainz Y., Montoya M.E., López de Ceráin A., Monge A. Die Pharmazie. 54:1999;24-25.